×

Power Play: Betting on large-cap growth this year

A pedestrian passes in front of the Pfizer headquarters in New York City.
Getty Images
A pedestrian passes in front of the Pfizer headquarters in New York City.

Stocks are down more than 4 percent since the beginning of the year, but this is not the time to panic. Robert Pavlik, chief market strategist at Boston Private Wealth, tells CNBC's"Power Lunch"on Thursday he is looking for opportunities.

"I am not expecting a recession, but what I do expect is a volatile trading environment, one that still carries with it a potential for the S&P 500 to gain around 6 percent for the year," Pavlik said.

Read MoreDow off 200 points again in choppy trade; Nasdaq falls 1.5%

He believes FANG stocks will be back in vogue as the Europe and energy trades fade. Until then, Pavlik is looking at some large-cap growth names.

"In health care, I like the major pharmaceutical firms such as Pfizer. I also like Express Scripts," Pavlik said. In the consumer space, Pavlik's favorites are CVS, Home Depot and Starbucks.

Pfizer, Express Scripts, CVS, Home Depot and Starbucks are all lower during trading.